Durvalumab vs Levofloxacin

Durvalumab vs Levofloxacin: Overview

This comparison examines the pharmacological differences between Durvalumab and Levofloxacin.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Levofloxacin: Fluoroquinolone antibiotic inhibiting bacterial DNA gyrase and topoisomerase IV.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Levofloxacin — 6-8 hours.

Chemical Properties

Molecular Formula: Levofloxacin — C18H20FN3O4.

Molecular Weight: Levofloxacin — 361.3680 g/mol.

Type: Durvalumab — Antibody; Levofloxacin — Small molecule.